Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | unknown | PO / MO |
The patient took four doses of Vivotif with food; Case reference number US-BN-2025-000861 is a spontaneous case initially received from nurse via Communication (reference number: USBAV25-0917) on 23-APR-2025 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took with food four doses of Vivotif (batch number: unknown) at dose of capsules, orally, at unknown dose, for indication travel (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if patient experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: A female patient of unspecified age took four doses of Vivotif with food for indication travel, which is considered as product administration error. It was unknown if patient experienced any adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age took four doses of Vivotif with food for indication travel, which is considered as product administration error. It was unknown if patient experienced any adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE